Processing joint Food and Drug Administration and European Medicines Agency voluntary genomic data submissions within the framework of the confidentiality arrangement

  • Email
  • Help
Current version

Adopted guideline

Published19/05/2006
Effective from19/05/2006
KeywordsJoint FDA-EMA voluntary genomic data submission (VGDS)
DescriptionThis document explains how the U.S. Food and Drug Administration and the European Medicines Agency will process requests for joint FDA-EMA voluntary genomic data submission (VGDS) briefing meetings.

How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more